Add Company
Join Now

Incyclix Bio Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Incyclix Bio's estimated annual revenue is currently $542.5k per year.(i)
  • Incyclix Bio's estimated revenue per employee is $77,500

Employee Data

  • Incyclix Bio has 7 Employees.(i)
  • Incyclix Bio grew their employee count by 17% last year.

Incyclix Bio's People

NameTitleEmail/Phone
1
Co-Founder, SVPReveal Email/Phone
2
CEO and Co-FounderReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.2M72-13%N/AN/A
#2
$5099.8M32902-4%N/AN/A
#3
$1.7M110%N/AN/A
#4
$0.6M4-56%N/AN/A
#5
$0.9M11-39%N/AN/A
#6
$1.7M1110%N/AN/A
#7
$0.6M4-33%N/AN/A
#8
$4.8M31-6%N/AN/A
#9
$6.4M413%N/AN/A
#10
$4.2M27-18%N/AN/A
Add Company

What Is Incyclix Bio?

Incyclix Bio, LLC is a next-generation cell cycle control company, advancing precision treatments that target the aberrant proliferation driving many cancers. The company’s lead compound is a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor nearing clinical stage. Incyclix Bio is a scientific leader in understanding cyclin-dependent kinases (CDKs) and their role in the cell cycle as attractive therapeutic targets across many tumor types, including ovarian, breast and lung cancers. Headquartered in Research Triangle Park, NC, Incyclix Bio is founded by pioneers in CDK inhibitor discovery, research and development.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$542.5k

Revenue (est)

17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.1M70%N/A
#2
$0.5M7-36%N/A
#3
$1.1M70%N/A
#4
$0.5M7-12%N/A
#5
$0.5M7-30%N/A